Analysis Group Health Care Consultants Present at Pharmacoepidemiology and Drug Safety Conference
August 10, 2016
Researchers from Analysis Group's Health Care Consulting practice will make three podium and four poster presentations at the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Dublin, Ireland. The conference takes place from August 25 to 28, 2016, and brings together epidemiologists in the pharmaceutical, legal, and health insurance industries, as well as in academia.
Our podium presentations will examine the impact of paliperidone palmitate versus oral atypical antipsychotics, the comparative hepatotoxicity of echinocandins, and the epidemiology of advanced pancreatic neuroendocrinetumors in the era of targeted therapy. In addition, our research posters will explore aspects of thalassemia intermedia in the US, adult patients with sporadic angiomyolipoma in the Netherlands, the impact of long acting reversible contraceptive use in a commercially insured population, and patient characteristics and overall survival in the metastatic castration-resistant prostate cancer community setting.
Research contributors from Analysis Group include Managing Principals Mei Sheng Duh and Patrick Lefebvre; Vice President Francis Vekeman; Managers Wendy Cheng and Lynn Huynh; Senior Economists Raluca Ionescu-Ittu and François Laliberté; Economists Jonathan Fortier, Marjolaine Gauthier-Loiselle, Laurence Gozalo, Dominic Pilon, and Yongling Xiao; and Senior Analyst Nora McCormick.
Analysis Group will also host an exhibit booth at the conference.